4//SEC Filing
Pieton Thierry 4
Accession 0001613103-25-000029
CIK 0001613103other
Filed
Mar 4, 7:00 PM ET
Accepted
Mar 5, 5:22 PM ET
Size
11.4 KB
Accession
0001613103-25-000029
Insider Transaction Report
Form 4
Pieton Thierry
EVP & Chief Financial Officer
Transactions
- Award
Ordinary Shares
2025-03-03$94.30/sh+4,242$400,021→ 4,242 total - Award
Performance Share Unit
2025-03-03+10,605→ 10,605 total→ Performance Share Units (10,605 underlying) - Award
Stock Option (Right to Buy)
2025-03-03+29,574→ 29,574 totalExercise: $94.30Exp: 2035-03-03→ Ordinary Shares (29,574 underlying) - Award
Ordinary Shares
2025-03-03$94.30/sh+26,512$2,500,082→ 30,754 total
Footnotes (6)
- [F1]Represents restricted stock units that vest 100% on the third anniversary of the date of grant.
- [F2]Represents restricted stock units that vest in three annual installments beginning one year from the date of grant.
- [F3]Each performance share unit represents a contingent right to receive one share of Medtronic common stock.
- [F4]Vests on April 30, 2027.
- [F5]The number of shares to be issued in connection with the performance share units ("PSUs") will vary depending on the level of certain performance metrics achieved over a three (3) year performance period. If target performance metrics are achieved, 10,605 shares will be issued. If maximum performance metrics are achieved, 21,210 shares will be issued. If minimum performance metrics are not met, such PSUs may vest at 0 shares.
- [F6]The options are exercisable in four annual installments beginning one year from the date of grant.
Documents
Issuer
Medtronic plc
CIK 0001613103
Entity typeother
Related Parties
1- filerCIK 0002056622
Filing Metadata
- Form type
- 4
- Filed
- Mar 4, 7:00 PM ET
- Accepted
- Mar 5, 5:22 PM ET
- Size
- 11.4 KB